全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Use of Idarucizumab for dabigatran reversal: Emergency department experience in two cases with subdural haematoma

DOI: 10.1016/j.tcr.2017.12.003

Keywords: Idarucizumab, Dabigatran, Intracranial haemorrhage, Wounds and injuries, Emergency department

Full-Text   Cite this paper   Add to My Lib

Abstract:

Idarucizumab is the first effective humanized monoclonal antibody fragment developed specifically as a reversal agent for dabigatran, a Direct Oral Anticoagulant. Despite recent trials demonstrating reversal of clinically relevant bleeding, there is a paucity of data on use outside the trial setting. This manuscript describes the use of Idarucizumab to reverse dabigatran in two patients presenting to the emergency department of a major tertiary hospital with acute traumatic subdural haematomas (SDH)

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133